AMA
Fabiszewska S, Derda E, Szymańska E, Osiecki M, Kierkuś J. Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group. Pediatria Polska - Polish Journal of Paediatrics. 2023;98(2):123-132. doi:10.5114/polp.2023.128806.
APA
Fabiszewska, S., Derda, E., Szymańska, E., Osiecki, M., & Kierkuś, J. (2023). Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group. Pediatria Polska - Polish Journal of Paediatrics, 98(2), 123-132. https://doi.org/10.5114/polp.2023.128806
Chicago
Fabiszewska, Sylwia, Edyta Derda, Edyta Szymańska, Marcin Osiecki, and Jarosław Kierkuś. 2023. "Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group". Pediatria Polska - Polish Journal of Paediatrics 98 (2): 123-132. doi:10.5114/polp.2023.128806.
Harvard
Fabiszewska, S., Derda, E., Szymańska, E., Osiecki, M., and Kierkuś, J. (2023). Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group. Pediatria Polska - Polish Journal of Paediatrics, 98(2), pp.123-132. https://doi.org/10.5114/polp.2023.128806
MLA
Fabiszewska, Sylwia et al. "Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group." Pediatria Polska - Polish Journal of Paediatrics, vol. 98, no. 2, 2023, pp. 123-132. doi:10.5114/polp.2023.128806.
Vancouver
Fabiszewska S, Derda E, Szymańska E, Osiecki M, Kierkuś J. Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group. Pediatria Polska - Polish Journal of Paediatrics. 2023;98(2):123-132. doi:10.5114/polp.2023.128806.
